AAV-sh-Atp6i not only reduces bone loss (Fig. 3) and inflammation in periodontitis, but it is also inhibits periapical bone erosion and inflammation in the mouse model of endodontic disease [48] and may be useful for other diseases involving bone resorption and the immune system. Here, TCIRG1 is linked to periodontitis.